v3.26.1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Program and Executive Officer Appointment As described above, the Performance Options were eligible to be earned in three tranches based on the Company’s common stock reaching market trading prices (based on a trailing 60-day VWAP) before the seventh anniversary of the Program Effective Date, as set forth in the following table:
Earned Tranche
Shares Subject to the Performance Option
Share Price Hurdle
1
33.33% of award
$4.00
2
33.33% of award
$5.00
3
33.34% of award
$6.00
Schedule of Activity of Stock Options of Employee and Non-Employee
A summary of stock options as of March 31, 2026, and changes during the three months ended March 31, 2026, is presented below:
Options OutstandingWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Balance at December 31, 202521,829,679 $0.58 
Options granted— $— 
Options exercised— $— 
Options forfeited(128,000)$0.48 
Options expired— $— 
Balance at March 31, 202621,701,679 $0.58 5$33,000 
Exercisable at March 31, 202612,180,063 $0.70 2$7,000 
Schedule of Activity of Equity-Based RSUs
A summary of equity-based RSU activity is presented below:
Number of RSUsWeighted Average Grant Date Fair Value (per unit)
Balance at December 31, 202550,005 $3.89 
Granted— $— 
Vested and released— $— 
Forfeited— $— 
Balance at March 31, 202650,005 $3.89 
Schedule of Components of Stock-Based Compensation Expense
The components of stock-based compensation expense were as follows:
Three Months Ended March 31,
20262025
Stock options$99 $137 
Restricted common stock(1)
56 96 
Restricted stock units— 14 
Capitalized costs(2)
(1)4 
Total stock-based compensation expense$154 $251 
(1)    Shares of common stock issued to the Holders as merger consideration in the HDW acquisition that were treated as replacement awards of unvested HDW common stock.
(2)    Included in internally-developed software, net on the accompanying Condensed Consolidated Balance Sheets.
Stock-based compensation expense is included in cost of revenue, research and development, sales and marketing and general and administrative on the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss as follows:
Three Months Ended March 31,
20262025
Cost of revenue$— $1 
Research and development14 43 
Sales and marketing14 20 
General and administrative126 187 
Total stock-based compensation expense$154 $251